Delivery Order SPE2DB20D3103-SPE2DB25FQ1Q4
- Not listed
- The Defense Logistics Agency awarded a $6,515.94 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count packaging) with an ultimate completion date of August 12, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was issued as a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $27,766.85 to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count supply) on August 12, 2025, with an ultimate completion date of August 13, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,911.52 to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count units) on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price, non-set-aside contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $29,480.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count packages) on September 3, 2025, with completion scheduled for September 4, 2025. This non-set-aside contract was competitively awarded and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency's Medical Supply Chain for Ondansetron ODT 4mg tablets (30-count supply) valued at $48,173.20. The contract award, issued on August 25, 2025, with an ultimate completion date of September 22, 2025, utilizes firm fixed pricing with no set-aside designation. This delivery order represents a competitively awarded transaction under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a $2,461.52 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets in a 30-tablet quantity, with completion scheduled for August 26, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be performed and delivered from the contractor's...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on August 19, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $21,254.05 and an ultimate completion date of August 20, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. As a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $6,749.06 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30. The order, with an ultimate completion date of August 6, 2025, will be performed at the contractor's Conshohocken, Pennsylvania facility. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,441.71 firm fixed price delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count) on July 18, 2025, with completion scheduled for July 21, 2025. This non-set-aside contract represents a routine pharmaceutical procurement to support federal medical supply needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $6,100.80 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ1Q4Delivery Order
The Defense Logistics Agency awarded a $29,071.24 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count packages) on September 4, 2025, with completion due by September 5, 2025. This is a firm fixed price, non-set-aside contract performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a child contract under a larger vehicle, this delivery order leverages AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical prime vendor agreement running through December 2026 that provides comprehensive global pharmaceutical support to military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to supply a broad range of pharmaceutical products and medical supplies through competitively awarded, firm fixed price arrangements. Under its DLA Troop Support Medical indefinite delivery contract, the company supplies specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.1k | 9/4/25 |